Novo Nordisk Inc Drug Patent Portfolio
Novo Nordisk Inc owns 20 orange book drugs protected by 61 US patents with Prandimet having the least patent protection, holding only 1 patent. And Novolog Flextouch with maximum patent protection, holding 23 patents. Given below is the list of Novo Nordisk Inc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9968659 | Liraglutide in cardiovascular conditions | 09 Jul, 2037 | Active |
| US9968659 | Liraglutide in cardiovascular conditions | 09 Jan, 2037 | Active |
| US9265893 | Injection button | 23 Mar, 2033 | Active |
| US9265893 | Injection button | 23 Sep, 2032 | Active |
| US9132239 | Dial-down mechanism for wind-up pen | 01 Feb, 2032 | Active |
| US9457154 | Injection device with an end of dose feedback mechanism | 27 Sep, 2027 | Active |
| US9687611 | Injection device with torsion spring and rotatable display | 27 Feb, 2027 | Active |
| US7686786 | Dial-down mechanism for wind-up pen | 03 Aug, 2026 | Active |
| USRE46363 | Dial-down mechanism for wind-up pen | 03 Aug, 2026 | Active |
| US10220155 | Syringe device with a dose limiting mechanism and an additional safety mechanism | 17 Jul, 2026 | Active |
| US8920383 | Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left | 17 Jul, 2026 | Active |
| US9775953 | Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left | 17 Jul, 2026 | Active |
| US8114833 | Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices | 13 Feb, 2026 | Active |
| US10357616 | Injection device with an end of dose feedback mechanism | 20 Jan, 2026 | Active |
| US10376652 | Automatic injection device with a top release mechanism | 20 Jan, 2026 | Active |
| US9108002 | Automatic injection device with a top release mechanism | 20 Jan, 2026 | Active |
| US9616180 | Automatic injection device with a top release mechanism | 20 Jan, 2026 | Active |
| US9861757 | Injection device with an end of dose feedback mechanism | 20 Jan, 2026 | Active |
| US8684969 | Injection device with torsion spring and rotatable display | 20 Oct, 2025 | Active |
| US8114833 | Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices | 13 Aug, 2025 | Active |
| US7762994 | Needle mounting system and a method for mounting a needle assembly | 23 Nov, 2024 | Expired |
| US7762994 | Needle mounting system and a method for mounting a needle assembly | 23 May, 2024 | Expired |
| US8579869 | Needle mounting system and a method for mounting a needle assembly | 30 Dec, 2023 | Expired |
| US8579869 | Needle mounting system and a method for mounting a needle assembly | 30 Jun, 2023 | Expired |
| US6268343 | Derivatives of GLP-1 analogs | 22 Feb, 2023 | Expired |
| US8846618 | Stable formulation of modified GLP-1 | 27 Dec, 2022 | Expired |
| US7018992 | Hormone composition | 17 Sep, 2022 | Expired |
| US8846618 | Stable formulation of modified GLP-1 | 27 Jun, 2022 | Expired |
| US6899699 | Automatic injection device with reset feature | 02 Jan, 2022 | Expired |
| US8672898 | Automatic injection device with reset feature | 02 Jan, 2022 | Expired |
| US9486588 | Automatic injection device with reset feature | 02 Jan, 2022 | Expired |
| USRE41956 | Dose setting limiter | 21 Jul, 2021 | Expired |
| US6716198 | Injection device | 05 Jun, 2021 | Expired |
| USRE41956 | Dose setting limiter | 21 Jan, 2021 | Expired |
| US6004297 | Injection syringe | 28 Jul, 2019 | Expired |
| US5750497 | Acylated insulin | 16 Jun, 2019 | Expired |
| US6004297 | Injection syringe | 28 Jan, 2019 | Expired |
| USRE43834 | Injection syringe | 28 Jan, 2019 | Expired |
| US6235004 | Injection syringe | 28 Jan, 2019 | Expired |
| US6677358 | NIDDM regimen | 12 Jun, 2018 | Expired |
| US8841252 | Pharmaceutical formulation | 26 Dec, 2017 | Expired |
| US5866538 | Insulin preparations containing NaCl | 20 Dec, 2017 | Expired |
| US6268343 | Derivatives of GLP-1 analogs | 22 Aug, 2017 | Expired |
| US6458924 | Derivatives of GLP-1 analogs | 22 Aug, 2017 | Expired |
| US7235627 | Derivatives of GLP-1 analogs | 22 Aug, 2017 | Expired |
| US5860946 | Instrument for inserting a suppository | 01 Jul, 2017 | Expired |
| US5866538 | Insulin preparations containing NaCl | 20 Jun, 2017 | Expired |
| US5849700 | Pharmaceutical formulation | 15 Dec, 2015 | Expired |
| US5849704 | Pharmaceutical formulation | 15 Dec, 2015 | Expired |
| US5693027 | Adaptor top | 02 Jun, 2015 | Expired |
| US5618913 | Insulin analogues | 07 Dec, 2014 | Expired |
| US5693027 | Adaptor top | 02 Dec, 2014 | Expired |
| US5626566 | Large dose pen | 06 Nov, 2014 | Expired |
| US5618913 | Insulin analogues | 07 Jun, 2014 | Expired |
| US5633352 | Biosynthetic human growth hormone | 27 May, 2014 | Expired |
| US5626566 | Large dose pen | 06 May, 2014 | Expired |
| US6011007 | Acylated insulin | 02 Feb, 2014 | Expired |
| US6869930 | Acylated insulin | 02 Feb, 2014 | Expired |
| US5547930 | AspB28 insulin crystals | 28 Sep, 2013 | Expired |
| US5834422 | AspB28 insulin compositions | 28 Sep, 2013 | Expired |
| US5840680 | ASPB28 insulin crystals | 28 Sep, 2013 | Expired |
Latest Legal Activities on Novo Nordisk Inc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Novo Nordisk Inc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Maintenance Fee Reminder Mailed
Critical
| 01 Jul, 2024 | US9486588 |
|
Maintenance Fee Reminder Mailed
Critical
| 01 Jul, 2024 | US9486588 |
|
Maintenance Fee Reminder Mailed
Critical
| 01 Jul, 2024 | US9486588 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 21 Mar, 2024 | US9457154 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 21 Mar, 2024 | US9457154 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 21 Mar, 2024 | US9457154 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 21 Feb, 2023 | US9132239 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 21 Feb, 2023 | US9132239 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 21 Feb, 2023 | US9132239 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 21 Jan, 2023 | US10376652 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 21 Jan, 2023 | US9108002 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 21 Jan, 2023 | US9108002 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 21 Jan, 2023 | US9108002 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 21 Jan, 2023 | US10376652 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 21 Jan, 2023 | US10376652 |
Novo Nordisk Inc's Drug Patent Litigations
Novo Nordisk Inc's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Jan 23, 2014, against patent number US9265893. The petitioner , challenged the validity of this patent, with Torben Stroem Hansen et al as the respondent. Click below to track the latest information on how companies are challenging Novo Nordisk Inc's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US8114833 | March, 2022 |
Terminated-Settled
(08 Sep, 2022)
| Novo Nordisk A/S | Fresenius Kabi USA, LLC |
| US8114833 | December, 2019 |
Terminated-Settled
(21 Jun, 2021)
| Novo Nordisk A/S et al. | Pfizer Inc. et al. |
| US8114833 | July, 2020 |
Terminated-Settled
(21 Jun, 2021)
| Novo Nordisk A/S | Pfizer Inc. |
| US9265893 | January, 2014 |
Decision
(08 Sep, 2015)
| Torben Stroem Hansen et al | |
Novo Nordisk Inc Drug Patents' Oppositions Filed in EPO
Novo Nordisk Inc drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Feb 23, 2006, by Owen Mumford Limited. This opposition was filed on patent number EP02726984A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
| | |||
| EP02726984A | NA | Genentech, Inc. | Patent maintained as amended |
| EP17710160A | May, 2022 | STADA Arzneimittel AG | Granted and Under Opposition |
| EP17710160A | May, 2022 | Dr. Schön, Neymeyr & Partner Patentanwälte mbB | Granted and Under Opposition |
| EP17710160A | May, 2022 | Adalvo Ltd. | Granted and Under Opposition |
| EP17710160A | May, 2022 | SANDOZ AG | Granted and Under Opposition |
| EP17710160A | Apr, 2022 | Teva Pharmaceutical Industries Ltd. | Granted and Under Opposition |
| EP17196501A | Dec, 2019 | Hoffmann Eitle | Granted and Under Opposition |
| EP17196501A | Dec, 2019 | Generics (U.K.) Limited | Granted and Under Opposition |
| EP17196501A | Dec, 2019 | Dr. Reddy's Laboratories Limited | Granted and Under Opposition |
| EP17196501A | Dec, 2019 | Galenicum Health S.L.U. | Granted and Under Opposition |
| EP17196501A | Dec, 2019 | Teva Pharmaceutical Industries Ltd | Granted and Under Opposition |
| EP04797453A | Aug, 2018 | Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB | Opposition rejected |
| EP04797453A | Aug, 2018 | Generics (U.K.) Limited | Opposition rejected |
| EP04797453A | Aug, 2018 | Teva Pharmaceutical Industries Ltd | Opposition rejected |
| EP04797453A | Aug, 2018 | Wittkopp, Alexander | Opposition rejected |
| EP04797453A | Aug, 2018 | Fresenius Kabi Deutschland GmbH | Opposition rejected |
| EP04797453A | Aug, 2018 | Sandoz AG | Opposition rejected |
| EP06701034A | Jan, 2018 | Schwöbel, Thilo | Opposition rejected |
| EP01270333A | Aug, 2012 | Helm AG | Revoked |
| EP01270333A | Aug, 2012 | Laboratorios Léon Farma, S.A. | Revoked |
| EP06754730A | Dec, 2011 | Ypsomed AG | Patent maintained as amended |
| EP06754730A | Nov, 2011 | WMC Matthes Consulting | Patent maintained as amended |
| EP08708028A | Jul, 2011 | Bock Wolfgang | Patent maintained as amended |
| EP06762643A | Jul, 2010 | Sanofi-Aventis Deutschland GmbH | Patent maintained as amended |
| EP05796880A | Jul, 2010 | Stöckeler, Ferdinand | Granted and Under Opposition |
| EP05796880A | Jul, 2010 | Ypsomed AG | Granted and Under Opposition |
| EP05796880A | Jul, 2010 | Ferring International Center S.A. | Granted and Under Opposition |
| EP05796880A | Jul, 2010 | OWEN MUMFORD LIMITED | Granted and Under Opposition |
| EP05796880A | Jul, 2010 | COPERNICUS sp. zo.o. | Granted and Under Opposition |
| EP05796880A | Jul, 2010 | Genentech, Inc. | Granted and Under Opposition |
| EP06121820A | May, 2010 | SANOFI-AVENTIS DEUTSCHLAND GMBH | Opposition rejected |
| EP02745182A | Sep, 2008 | AMYLIN PHARMACEUTICALS, INC. | Opposition rejected |
| EP02726984A | Mar, 2006 | TecPharma Licensing AG | Patent maintained as amended |
| EP02726984A | Feb, 2006 | OWEN MUMFORD LIMITED | Patent maintained as amended |
Novo Nordisk Inc's Family Patents
Novo Nordisk Inc Drug List
Given below is the complete list of Novo Nordisk Inc's drugs and the patents protecting them.
1. Levemir
Levemir is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5750497 | Acylated insulin |
16 Jun, 2019
(5 years ago)
| Expired |
| US5866538 | Insulin preparations containing NaCl |
20 Jun, 2017
(7 years ago)
| Expired |
| US6011007 | Acylated insulin |
02 Feb, 2014
(10 years ago)
| Expired |
| US6869930 | Acylated insulin |
02 Feb, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Levemir's drug page
2. Levemir Flexpen
Levemir Flexpen is protected by 8 patents, out of which 7 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9265893 | Injection button |
23 Sep, 2032
(7 years from now)
| Active |
| USRE41956 | Dose setting limiter |
21 Jan, 2021
(3 years ago)
| Expired |
| US5750497 | Acylated insulin |
16 Jun, 2019
(5 years ago)
| Expired |
| US6004297 | Injection syringe |
28 Jan, 2019
(5 years ago)
| Expired |
| USRE43834 | Injection syringe |
28 Jan, 2019
(5 years ago)
| Expired |
| US5866538 | Insulin preparations containing NaCl |
20 Jun, 2017
(7 years ago)
| Expired |
| US6011007 | Acylated insulin |
02 Feb, 2014
(10 years ago)
| Expired |
| US6869930 | Acylated insulin |
02 Feb, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Levemir Flexpen's drug page
3. Levemir Flextouch
Levemir Flextouch is protected by 21 patents, out of which 7 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9132239 | Dial-down mechanism for wind-up pen |
01 Feb, 2032
(7 years from now)
| Active |
| US9457154 | Injection device with an end of dose feedback mechanism |
27 Sep, 2027
(2 years from now)
| Active |
| US9687611 | Injection device with torsion spring and rotatable display |
27 Feb, 2027
(2 years from now)
| Active |
| US7686786 | Dial-down mechanism for wind-up pen |
03 Aug, 2026
(1 year, 7 months from now)
| Active |
| USRE46363 | Dial-down mechanism for wind-up pen |
03 Aug, 2026
(1 year, 7 months from now)
| Active |
| US10220155 | Syringe device with a dose limiting mechanism and an additional safety mechanism |
17 Jul, 2026
(1 year, 6 months from now)
| Active |
| US8920383 | Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left |
17 Jul, 2026
(1 year, 6 months from now)
| Active |
| US9775953 | Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left |
17 Jul, 2026
(1 year, 6 months from now)
| Active |
| US10357616 | Injection device with an end of dose feedback mechanism |
20 Jan, 2026
(1 year, 29 days from now)
| Active |
| US10376652 | Automatic injection device with a top release mechanism |
20 Jan, 2026
(1 year, 29 days from now)
| Active |
| US9108002 | Automatic injection device with a top release mechanism |
20 Jan, 2026
(1 year, 29 days from now)
| Active |
| US9616180 | Automatic injection device with a top release mechanism |
20 Jan, 2026
(1 year, 29 days from now)
| Active |
| US9861757 | Injection device with an end of dose feedback mechanism |
20 Jan, 2026
(1 year, 29 days from now)
| Active |
| US8684969 | Injection device with torsion spring and rotatable display |
20 Oct, 2025
(9 months from now)
| Active |
| US7762994 | Needle mounting system and a method for mounting a needle assembly |
23 May, 2024
(6 months ago)
| Expired |
| US8579869 | Needle mounting system and a method for mounting a needle assembly |
30 Jun, 2023
(1 year, 5 months ago)
| Expired |
| US6899699 | Automatic injection device with reset feature |
02 Jan, 2022
(2 years ago)
| Expired |
| US8672898 | Automatic injection device with reset feature |
02 Jan, 2022
(2 years ago)
| Expired |
| US9486588 | Automatic injection device with reset feature |
02 Jan, 2022
(2 years ago)
| Expired |
| US5750497 | Acylated insulin |
16 Jun, 2019
(5 years ago)
| Expired |
| US5866538 | Insulin preparations containing NaCl |
20 Jun, 2017
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Levemir Flextouch's drug page
4. Levemir Innolet
Levemir Innolet is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5750497 | Acylated insulin |
16 Jun, 2019
(5 years ago)
| Expired |
| US5866538 | Insulin preparations containing NaCl |
20 Jun, 2017
(7 years ago)
| Expired |
| US6011007 | Acylated insulin |
02 Feb, 2014
(10 years ago)
| Expired |
| US6869930 | Acylated insulin |
02 Feb, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Levemir Innolet's drug page
5. Levemir Penfill
Levemir Penfill is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5750497 | Acylated insulin |
16 Jun, 2019
(5 years ago)
| Expired |
| US5866538 | Insulin preparations containing NaCl |
20 Jun, 2017
(7 years ago)
| Expired |
| US6011007 | Acylated insulin |
02 Feb, 2014
(10 years ago)
| Expired |
| US6869930 | Acylated insulin |
02 Feb, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Levemir Penfill's drug page
Explore Our Curated Drug Screens
6. Norditropin
Norditropin is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5849700 | Pharmaceutical formulation |
15 Dec, 2015
(9 years ago)
| Expired |
| US5849704 | Pharmaceutical formulation |
15 Dec, 2015
(9 years ago)
| Expired |
| US5633352 | Biosynthetic human growth hormone |
27 May, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Norditropin's drug page
7. Norditropin Flexpro
Norditropin Flexpro is protected by 23 patents, out of which 9 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9132239 | Dial-down mechanism for wind-up pen |
01 Feb, 2032
(7 years from now)
| Active |
| US9457154 | Injection device with an end of dose feedback mechanism |
27 Sep, 2027
(2 years from now)
| Active |
| US9687611 | Injection device with torsion spring and rotatable display |
27 Feb, 2027
(2 years from now)
| Active |
| US7686786 | Dial-down mechanism for wind-up pen |
03 Aug, 2026
(1 year, 7 months from now)
| Active |
| USRE46363 | Dial-down mechanism for wind-up pen |
03 Aug, 2026
(1 year, 7 months from now)
| Active |
| US10220155 | Syringe device with a dose limiting mechanism and an additional safety mechanism |
17 Jul, 2026
(1 year, 6 months from now)
| Active |
| US8920383 | Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left |
17 Jul, 2026
(1 year, 6 months from now)
| Active |
| US9775953 | Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left |
17 Jul, 2026
(1 year, 6 months from now)
| Active |
| US10357616 | Injection device with an end of dose feedback mechanism |
20 Jan, 2026
(1 year, 29 days from now)
| Active |
| US10376652 | Automatic injection device with a top release mechanism |
20 Jan, 2026
(1 year, 29 days from now)
| Active |
| US9108002 | Automatic injection device with a top release mechanism |
20 Jan, 2026
(1 year, 29 days from now)
| Active |
| US9616180 | Automatic injection device with a top release mechanism |
20 Jan, 2026
(1 year, 29 days from now)
| Active |
| US9861757 | Injection device with an end of dose feedback mechanism |
20 Jan, 2026
(1 year, 29 days from now)
| Active |
| US8684969 | Injection device with torsion spring and rotatable display |
20 Oct, 2025
(9 months from now)
| Active |
| US7762994 | Needle mounting system and a method for mounting a needle assembly |
23 May, 2024
(6 months ago)
| Expired |
| US8579869 | Needle mounting system and a method for mounting a needle assembly |
30 Jun, 2023
(1 year, 5 months ago)
| Expired |
| US6899699 | Automatic injection device with reset feature |
02 Jan, 2022
(2 years ago)
| Expired |
| US8672898 | Automatic injection device with reset feature |
02 Jan, 2022
(2 years ago)
| Expired |
| US9486588 | Automatic injection device with reset feature |
02 Jan, 2022
(2 years ago)
| Expired |
| US6716198 | Injection device |
05 Jun, 2021
(3 years ago)
| Expired |
| US8841252 | Pharmaceutical formulation |
26 Dec, 2017
(6 years ago)
| Expired |
| US5849700 | Pharmaceutical formulation |
15 Dec, 2015
(9 years ago)
| Expired |
| US5849704 | Pharmaceutical formulation |
15 Dec, 2015
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Norditropin Flexpro's drug page
8. Norditropin Nordiflex
Norditropin Nordiflex is protected by 7 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| USRE41956 | Dose setting limiter |
21 Jan, 2021
(3 years ago)
| Expired |
| US6004297 | Injection syringe |
28 Jan, 2019
(5 years ago)
| Expired |
| US6235004 | Injection syringe |
28 Jan, 2019
(5 years ago)
| Expired |
| USRE43834 | Injection syringe |
28 Jan, 2019
(5 years ago)
| Expired |
| US8841252 | Pharmaceutical formulation |
26 Dec, 2017
(6 years ago)
| Expired |
| US5849700 | Pharmaceutical formulation |
15 Dec, 2015
(9 years ago)
| Expired |
| US5849704 | Pharmaceutical formulation |
15 Dec, 2015
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Norditropin Nordiflex's drug page
9. Novolog
Novolog is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5866538
(Pediatric)
| Insulin preparations containing NaCl |
20 Dec, 2017
(7 years ago)
| Expired |
| US5866538 | Insulin preparations containing NaCl |
20 Jun, 2017
(7 years ago)
| Expired |
| US5618913
(Pediatric)
| Insulin analogues |
07 Dec, 2014
(10 years ago)
| Expired |
| US5618913 | Insulin analogues |
07 Jun, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Novolog's drug page
10. Novolog Flexpen
Novolog Flexpen is protected by 12 patents, out of which 11 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9265893 | Injection button |
23 Sep, 2032
(7 years from now)
| Active |
| US7762994 | Needle mounting system and a method for mounting a needle assembly |
23 May, 2024
(6 months ago)
| Expired |
| US8579869 | Needle mounting system and a method for mounting a needle assembly |
30 Jun, 2023
(1 year, 5 months ago)
| Expired |
| USRE41956
(Pediatric)
| Dose setting limiter |
21 Jul, 2021
(3 years ago)
| Expired |
| USRE41956 | Dose setting limiter |
21 Jan, 2021
(3 years ago)
| Expired |
| US6004297
(Pediatric)
| Injection syringe |
28 Jul, 2019
(5 years ago)
| Expired |
| US6004297 | Injection syringe |
28 Jan, 2019
(5 years ago)
| Expired |
| USRE43834 | Injection syringe |
28 Jan, 2019
(5 years ago)
| Expired |
| US5866538
(Pediatric)
| Insulin preparations containing NaCl |
20 Dec, 2017
(7 years ago)
| Expired |
| US5866538 | Insulin preparations containing NaCl |
20 Jun, 2017
(7 years ago)
| Expired |
| US5618913
(Pediatric)
| Insulin analogues |
07 Dec, 2014
(10 years ago)
| Expired |
| US5618913 | Insulin analogues |
07 Jun, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Novolog Flexpen's drug page
11. Novolog Flextouch
Novolog Flextouch is protected by 23 patents, out of which 9 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9132239 | Dial-down mechanism for wind-up pen |
01 Feb, 2032
(7 years from now)
| Active |
| US9457154 | Injection device with an end of dose feedback mechanism |
27 Sep, 2027
(2 years from now)
| Active |
| US9687611 | Injection device with torsion spring and rotatable display |
27 Feb, 2027
(2 years from now)
| Active |
| US7686786 | Dial-down mechanism for wind-up pen |
03 Aug, 2026
(1 year, 7 months from now)
| Active |
| USRE46363 | Dial-down mechanism for wind-up pen |
03 Aug, 2026
(1 year, 7 months from now)
| Active |
| US10220155 | Syringe device with a dose limiting mechanism and an additional safety mechanism |
17 Jul, 2026
(1 year, 6 months from now)
| Active |
| US8920383 | Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left |
17 Jul, 2026
(1 year, 6 months from now)
| Active |
| US9775953 | Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left |
17 Jul, 2026
(1 year, 6 months from now)
| Active |
| US10357616 | Injection device with an end of dose feedback mechanism |
20 Jan, 2026
(1 year, 29 days from now)
| Active |
| US10376652 | Automatic injection device with a top release mechanism |
20 Jan, 2026
(1 year, 29 days from now)
| Active |
| US9108002 | Automatic injection device with a top release mechanism |
20 Jan, 2026
(1 year, 29 days from now)
| Active |
| US9616180 | Automatic injection device with a top release mechanism |
20 Jan, 2026
(1 year, 29 days from now)
| Active |
| US9861757 | Injection device with an end of dose feedback mechanism |
20 Jan, 2026
(1 year, 29 days from now)
| Active |
| US8684969 | Injection device with torsion spring and rotatable display |
20 Oct, 2025
(9 months from now)
| Active |
| US7762994 | Needle mounting system and a method for mounting a needle assembly |
23 May, 2024
(6 months ago)
| Expired |
| US8579869 | Needle mounting system and a method for mounting a needle assembly |
30 Jun, 2023
(1 year, 5 months ago)
| Expired |
| US6899699 | Automatic injection device with reset feature |
02 Jan, 2022
(2 years ago)
| Expired |
| US8672898 | Automatic injection device with reset feature |
02 Jan, 2022
(2 years ago)
| Expired |
| US9486588 | Automatic injection device with reset feature |
02 Jan, 2022
(2 years ago)
| Expired |
| US5866538
(Pediatric)
| Insulin preparations containing NaCl |
20 Dec, 2017
(7 years ago)
| Expired |
| US5866538 | Insulin preparations containing NaCl |
20 Jun, 2017
(7 years ago)
| Expired |
| US5618913
(Pediatric)
| Insulin analogues |
07 Dec, 2014
(10 years ago)
| Expired |
| US5618913 | Insulin analogues |
07 Jun, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Novolog Flextouch's drug page
12. Novolog Innolet
Novolog Innolet is protected by 6 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| USRE41956
(Pediatric)
| Dose setting limiter |
21 Jul, 2021
(3 years ago)
| Expired |
| USRE41956 | Dose setting limiter |
21 Jan, 2021
(3 years ago)
| Expired |
| US5866538
(Pediatric)
| Insulin preparations containing NaCl |
20 Dec, 2017
(7 years ago)
| Expired |
| US5866538 | Insulin preparations containing NaCl |
20 Jun, 2017
(7 years ago)
| Expired |
| US5618913
(Pediatric)
| Insulin analogues |
07 Dec, 2014
(10 years ago)
| Expired |
| US5618913 | Insulin analogues |
07 Jun, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Novolog Innolet's drug page
13. Novolog Mix 50/50
Novolog Mix 50/50 is protected by 7 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5866538
(Pediatric)
| Insulin preparations containing NaCl |
20 Dec, 2017
(7 years ago)
| Expired |
| US5866538 | Insulin preparations containing NaCl |
20 Jun, 2017
(7 years ago)
| Expired |
| US5618913
(Pediatric)
| Insulin analogues |
07 Dec, 2014
(10 years ago)
| Expired |
| US5618913 | Insulin analogues |
07 Jun, 2014
(10 years ago)
| Expired |
| US5547930 | AspB28 insulin crystals |
28 Sep, 2013
(11 years ago)
| Expired |
| US5834422 | AspB28 insulin compositions |
28 Sep, 2013
(11 years ago)
| Expired |
| US5840680 | ASPB28 insulin crystals |
28 Sep, 2013
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Novolog Mix 50/50's drug page
14. Novolog Mix 70/30
Novolog Mix 70/30 is protected by 7 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5866538
(Pediatric)
| Insulin preparations containing NaCl |
19 Dec, 2017
(7 years ago)
| Expired |
| US5866538 | Insulin preparations containing NaCl |
19 Jun, 2017
(7 years ago)
| Expired |
| US5618913
(Pediatric)
| Insulin analogues |
07 Dec, 2014
(10 years ago)
| Expired |
| US5618913 | Insulin analogues |
07 Jun, 2014
(10 years ago)
| Expired |
| US5547930 | AspB28 insulin crystals |
28 Sep, 2013
(11 years ago)
| Expired |
| US5834422 | AspB28 insulin compositions |
28 Sep, 2013
(11 years ago)
| Expired |
| US5840680 | ASPB28 insulin crystals |
28 Sep, 2013
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Novolog Mix 70/30's drug page
15. Novolog Mix 70/30 Flexpen
Novolog Mix 70/30 Flexpen is protected by 13 patents, out of which 12 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9265893 | Injection button |
23 Sep, 2032
(7 years from now)
| Active |
| US7762994 | Needle mounting system and a method for mounting a needle assembly |
23 May, 2024
(6 months ago)
| Expired |
| US8579869 | Needle mounting system and a method for mounting a needle assembly |
30 Jun, 2023
(1 year, 5 months ago)
| Expired |
| USRE41956 | Dose setting limiter |
21 Jan, 2021
(3 years ago)
| Expired |
| US6004297 | Injection syringe |
28 Jan, 2019
(5 years ago)
| Expired |
| USRE43834 | Injection syringe |
28 Jan, 2019
(5 years ago)
| Expired |
| US5866538
(Pediatric)
| Insulin preparations containing NaCl |
19 Dec, 2017
(7 years ago)
| Expired |
| US5866538 | Insulin preparations containing NaCl |
19 Jun, 2017
(7 years ago)
| Expired |
| US5618913
(Pediatric)
| Insulin analogues |
07 Dec, 2014
(10 years ago)
| Expired |
| US5618913 | Insulin analogues |
07 Jun, 2014
(10 years ago)
| Expired |
| US5547930 | AspB28 insulin crystals |
28 Sep, 2013
(11 years ago)
| Expired |
| US5834422 | AspB28 insulin compositions |
28 Sep, 2013
(11 years ago)
| Expired |
| US5840680 | ASPB28 insulin crystals |
28 Sep, 2013
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Novolog Mix 70/30 Flexpen's drug page
16. Novolog Mix 70/30 Penfill
Novolog Mix 70/30 Penfill is protected by 7 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5866538
(Pediatric)
| Insulin preparations containing NaCl |
19 Dec, 2017
(7 years ago)
| Expired |
| US5866538 | Insulin preparations containing NaCl |
19 Jun, 2017
(7 years ago)
| Expired |
| US5618913
(Pediatric)
| Insulin analogues |
07 Dec, 2014
(10 years ago)
| Expired |
| US5618913 | Insulin analogues |
07 Jun, 2014
(10 years ago)
| Expired |
| US5547930 | AspB28 insulin crystals |
28 Sep, 2013
(11 years ago)
| Expired |
| US5834422 | AspB28 insulin compositions |
28 Sep, 2013
(11 years ago)
| Expired |
| US5840680 | ASPB28 insulin crystals |
28 Sep, 2013
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Novolog Mix 70/30 Penfill's drug page
17. Novolog Penfill
Novolog Penfill is protected by 10 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7762994 | Needle mounting system and a method for mounting a needle assembly |
23 May, 2024
(6 months ago)
| Expired |
| US8579869 | Needle mounting system and a method for mounting a needle assembly |
30 Jun, 2023
(1 year, 5 months ago)
| Expired |
| US5866538
(Pediatric)
| Insulin preparations containing NaCl |
20 Dec, 2017
(7 years ago)
| Expired |
| US5866538 | Insulin preparations containing NaCl |
20 Jun, 2017
(7 years ago)
| Expired |
| US5693027
(Pediatric)
| Adaptor top |
02 Jun, 2015
(9 years ago)
| Expired |
| US5618913
(Pediatric)
| Insulin analogues |
07 Dec, 2014
(10 years ago)
| Expired |
| US5693027 | Adaptor top |
02 Dec, 2014
(10 years ago)
| Expired |
| US5626566
(Pediatric)
| Large dose pen |
06 Nov, 2014
(10 years ago)
| Expired |
| US5618913 | Insulin analogues |
07 Jun, 2014
(10 years ago)
| Expired |
| US5626566 | Large dose pen |
06 May, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Novolog Penfill's drug page
18. Prandimet
Prandimet is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6677358 | NIDDM regimen |
12 Jun, 2018
(6 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Prandimet's drug page
19. Vagifem
Vagifem is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7018992 | Hormone composition |
17 Sep, 2022
(2 years ago)
| Expired |
| US5860946 | Instrument for inserting a suppository |
01 Jul, 2017
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vagifem's drug page
20. Victoza
Victoza is protected by 20 patents, out of which 14 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9968659
(Pediatric)
| Liraglutide in cardiovascular conditions |
09 Jul, 2037
(12 years from now)
| Active |
| US9968659 | Liraglutide in cardiovascular conditions |
09 Jan, 2037
(12 years from now)
| Active |
| US9265893
(Pediatric)
| Injection button |
23 Mar, 2033
(8 years from now)
| Active |
| US9265893 | Injection button |
23 Sep, 2032
(7 years from now)
| Active |
| US8114833
(Pediatric)
| Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices |
13 Feb, 2026
(1 year, 1 month from now)
| Active |
| US8114833 | Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices |
13 Aug, 2025
(7 months from now)
| Active |
| US7762994
(Pediatric)
| Needle mounting system and a method for mounting a needle assembly |
23 Nov, 2024
(28 days ago)
| Expired |
| US7762994 | Needle mounting system and a method for mounting a needle assembly |
23 May, 2024
(6 months ago)
| Expired |
| US8579869
(Pediatric)
| Needle mounting system and a method for mounting a needle assembly |
30 Dec, 2023
(11 months ago)
| Expired |
| US8579869 | Needle mounting system and a method for mounting a needle assembly |
30 Jun, 2023
(1 year, 5 months ago)
| Expired |
| US6268343
(Pediatric)
| Derivatives of GLP-1 analogs |
22 Feb, 2023
(1 year, 9 months ago)
| Expired |
| US8846618
(Pediatric)
| Stable formulation of modified GLP-1 |
27 Dec, 2022
(1 year, 11 months ago)
| Expired |
| US8846618 | Stable formulation of modified GLP-1 |
27 Jun, 2022
(2 years ago)
| Expired |
| USRE41956
(Pediatric)
| Dose setting limiter |
21 Jul, 2021
(3 years ago)
| Expired |
| USRE41956 | Dose setting limiter |
21 Jan, 2021
(3 years ago)
| Expired |
| US6004297 | Injection syringe |
28 Jan, 2019
(5 years ago)
| Expired |
| USRE43834 | Injection syringe |
28 Jan, 2019
(5 years ago)
| Expired |
| US6268343 | Derivatives of GLP-1 analogs |
22 Aug, 2017
(7 years ago)
| Expired |
| US6458924 | Derivatives of GLP-1 analogs |
22 Aug, 2017
(7 years ago)
| Expired |
| US7235627 | Derivatives of GLP-1 analogs |
22 Aug, 2017
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Victoza's drug page